Long non-coding RNA BBOX1-AS1 exacerbates esophageal squamous cell carcinoma development by regulating HOXB7/β-catenin axis

被引:9
作者
Sheng, Jinxiu [1 ,2 ]
Zhou, Mingxia [3 ]
Wang, Chang [1 ,2 ]
Jia, Jinlin [1 ,2 ]
Chu, Jie [1 ,2 ]
Ju, Chenxi [1 ,2 ]
Wan, Junhu [1 ,2 ]
He, Jing [4 ]
He, Fucheng [1 ,2 ]
机构
[1] Zhengzhou Univ, Dept Med Lab, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China
[2] Key Clin Lab Henan Prov, Zhengzhou 450052, Henan, Peoples R China
[3] Zhengzhou Univ, Dept Gastroenterol, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China
[4] Zhengzhou Univ, Dept Breast Surg, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China
关键词
Esophageal squamous cell carcinoma; Long non-coding RNA; BBOX1-AS1; HOXB7; beta-catenin; CANCER; PROGRESSION; LNCRNA; HOXB7;
D O I
10.1016/j.yexcr.2022.113117
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mounting evidence suggests that long non-coding RNAs play a critical role in the occurrence and development of human malignancies. Nonetheless, it remains unknown whether Gamma-Butyrobetaine Hydroxylase 1-Antisense RNA 1 (BBOX1-AS1) participates in the regulation of esophageal squamous cell carcinoma (ESCC) carcinogenesis. Herein, we validated that BBOX1-AS1 was notably overexpressed in ESCC tissues compared to the adjacent non-tumor tissues and significantly correlated with tumor sizes. BBOX1-AS1 enhanced the malignant behavior of ESCC cells in vitro, such as cell proliferation, migration, and invasion. In addition, knockdown of BBOX1-AS1 augmented the proportion of apoptotic cells in ESCC cells. Mechanistically, BBOX1-AS1 regulated HOXB7 expression, and rescue experiments indicated that silencing of HOXB7 could abolish the malignant phenotypes mediated by BBOX1-AS1 to a certain extent. Moreover, HOXB7 participated in the activation of the Wnt/ beta-catenin signaling pathway. In summary, our findings substantiated that BBOX1-AS1 could activate the Wnt/ beta-catenin pathway by upregulating HOXB7 expression to promote ESCC progression, providing a rationale to develop novel therapeutic approaches.
引用
收藏
页数:11
相关论文
共 32 条
[1]   LncRNA and mRNA integration network reconstruction reveals novel key regulators in esophageal squamous-cell carcinoma [J].
Alaei, Shervin ;
Sadeghi, Balal ;
Najafi, Ali ;
Masoudi-Nejad, Ali .
GENOMICS, 2019, 111 (01) :76-89
[2]   The let-7c/HoxB7 axis regulates the cell proliferation, migration and apoptosis in hepatocellular carcinoma [J].
Cai, Lijun ;
Wang, Zhangliu ;
Zheng, Huajun ;
Xu, Lei .
ANTI-CANCER DRUGS, 2020, 31 (01) :6-18
[3]   Long Non-Coding RNA in the Pathogenesis of Cancers [J].
Chi, Yujing ;
Wang, Di ;
Wang, Junpei ;
Yu, Weidong ;
Yang, Jichun .
CELLS, 2019, 8 (09)
[4]   LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis [J].
Chu, Jie ;
Li, Hongle ;
Xing, Yurong ;
Jia, Jinlin ;
Sheng, Jinxiu ;
Yang, Lijun ;
Sun, Kaiyan ;
Qu, Yunhui ;
Zhang, Yan ;
Yin, Huiqing ;
Wa, Junhu ;
He, Fucheng .
BIOMEDICINE & PHARMACOTHERAPY, 2019, 116
[5]   HOXB7 Overexpression Leads Triple-Negative Breast Cancer Cells to a Less Aggressive Phenotype [J].
de Bessa Garcia, Simone Aparecida ;
Araujo, Mafalda ;
Pereira, Tiago ;
Freitas, Renata .
BIOMEDICINES, 2021, 9 (05)
[6]   New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer [J].
Dongre, Anushka ;
Weinberg, Robert A. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2019, 20 (02) :69-84
[7]   Bromodomain-containing protein 9 promotes hepatocellular carcinoma progression via activating the Wnt/β-catenin signaling pathway [J].
Fang, Dan ;
Wang, Mu-Ru ;
Guan, Jia-Lun ;
Han, Ying-Ying ;
Sheng, Jia-Qi ;
Tian, De-An ;
Li, Pei-Yuan .
EXPERIMENTAL CELL RESEARCH, 2021, 406 (02)
[8]   Specific knockdown of HOXB7 inhibits cutaneous squamous cell carcinoma cell migration and invasion while inducing apoptosis via the Wnt/β-catenin signaling pathway [J].
Gao, Dong ;
Chen, Hong-Quan .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2018, 315 (05) :C675-C686
[9]   The global, regional, and national burden of gastro-oesophageal reflux disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 [J].
Dirac M.A. ;
Safiri S. ;
Tsoi D. ;
Adedoyin R.A. ;
Afshin A. ;
Akhlaghi N. ;
Alahdab F. ;
Almulhim A.M. ;
Amini S. ;
Ausloos F. ;
Bacha U. ;
Banach M. ;
Bhagavathula A.S. ;
Bijani A. ;
Biondi A. ;
Borzì A.M. ;
Colombara D. ;
Dagnew B. ;
Daryani A. ;
Davitoiu D.V. ;
Demeke F.M. ;
Demoz G.T. ;
Do H.P. ;
Etemadi A. ;
Farzadfar F. ;
Fischer F. ;
Gebre A.K. ;
Gebremariam H. ;
Gebremichael B. ;
Ghashghaee A. ;
Ghoshal U.C. ;
Hamidi S. ;
Hasankhani M. ;
Hassan S. ;
Hay S.I. ;
Hoang C.L. ;
Hole M.K. ;
Ikuta K.S. ;
Ilesanmi O.S. ;
Irvani S.S.N. ;
James S.L. ;
Joukar F. ;
Kabir A. ;
Kassaye H.G. ;
Kavetskyy T. ;
Kengne A.P. ;
Khalilov R. ;
Khan M.U. ;
Khan E.A. ;
Khan M. .
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (06) :561-581
[10]   METTL3 restrains papillary thyroid cancer neutrophil infiltration [J].
He, Jing ;
Zhou, Mingxia ;
Yin, Jie ;
Wan, Junhu ;
Chu, Jie ;
Jia, Jinlin ;
Sheng, Jinxiu ;
Wang, Chang ;
Yin, Huiqing ;
He, Fucheng .
MOLECULAR THERAPY, 2021, 29 (05) :1821-1837